Deep brain stimulation clinical trials: a framework to accelerate recruitment, retention, and technology translation
Frontiers in Human Neuroscience · 27.07.2026 · 20
DOI: 10.3389/fnhum.2026.1851931 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Human Neuroscience, online erschienen am 27.07.2026. Verfasst von Kara A Johnson und 9 weiteren Autor:innen. Beteiligte Einrichtung: Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, United States. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIMH NIH HHS.
Abstract (Originalsprache)
Clinical trials involving deep brain stimulation (DBS) are challenging to implement due to invasiveness and complexity of the therapy, substantial barriers to participant recruitment and retention, and difficulties translating emerging technologies into routine clinical practice. The 2023 Brain Research Through Advancing Innovative Neurotechnologies® (BRAIN) Workshop on Patient Recruitment in DBS Clinical Trials convened experts in clinical care, research, engineering, neuroethics, and device regulation to discuss barriers and facilitators related to recruitment, retention, and clinical translation of DBS technologies. The critical barriers to recruitment and retention included limited awareness and misinformation surrounding DBS, participant burden, and complex or inflexible trial protocols. Workshop participants identified several strategies to overcome these barriers, including improving public education, employing patient-centered study designs, engaging participants as equal stakeholders in the research, fostering partnerships with community organizations and referring clinicians, and reducing logistical, financial, and technological burdens associated with participation. Participants also identified barriers to broader clinical translation, including opaque pathways to regulatory approval and insurance coverage, access to specialized care, and adoption of new technologies. To overcome these challenges, participants emphasized the need for objective milestones, outcomes, and biomarkers, pragmatic study design, shared frameworks to support reimbursement efforts, and continued investment in multidisciplinary education and workforce development. Collectively, the workshop attendees concluded accelerating DBS innovation will require interdisciplinary collaborations among patients and patient advocates, community organizations, engineers, industry partners, researchers, clinicians, and regulatory stakeholders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, United States.
- Departments of Neurology and Neurosurgery, University of Florida, Gainesville, FL, United States.
- Department of Biomedical Engineering, University of Utah, Salt Lake City, UT, United States.
- Department of Neurosurgery, University of Utah, Salt Lake City, UT, United States.
- Department of Neurosurgery, Baylor College of Medicine, Houston, TX, United States.
- Department of Electrical and Computer Engineering, Rice University, Houston, TX, United States.
Förderung
- NINDS NIH HHS
- NIMH NIH HHS
Zitieren
APA
Johnson, K. A., Provenza, N. R., Robinson Schwartz, S. E., Yu, J., Merner, A. R., Neumann, W. J., Sheth, S. A., Wong, J. K., Okun, M. S., & Frankowski, M. M. (2026). Deep brain stimulation clinical trials: a framework to accelerate recruitment, retention, and technology translation. Frontiers in Human Neuroscience, 20. https://doi.org/10.3389/fnhum.2026.1851931
Vancouver
Johnson KA, Provenza NR, Robinson Schwartz SE, Yu J, Merner AR, Neumann WJ, et al. Deep brain stimulation clinical trials: a framework to accelerate recruitment, retention, and technology translation. Frontiers in Human Neuroscience. 2026;20. doi:10.3389/fnhum.2026.1851931
BibTeX
@article{Johnson2026,
author = {Johnson, Kara A and Provenza, Nicole R and Robinson Schwartz, Sarah E and Yu, Jun and Merner, Amanda R and Neumann, Wolf-Julian and Sheth, Sameer A and Wong, Joshua K and Okun, Michael S and Frankowski, Megan M},
title = {Deep brain stimulation clinical trials: a framework to accelerate recruitment, retention, and technology translation},
journal = {Frontiers in Human Neuroscience},
year = {2026},
volume = {20},
doi = {10.3389/fnhum.2026.1851931}
}
EUVIMED